Results 161 to 170 of about 5,090 (179)

Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors

Cancer Immunology, Immunotherapy, 2017
Reinhard Dummer, Christoph Hoeller, Olivier Michielin   +2 more
exaly  

Avelumab/talimogene laherparepvec/somatostatins

Reactions Weekly, 2023
openaire   +1 more source

Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma

Journal of Clinical Oncology, 2018
Igor Puzanov, Frances Collichio, Omid Hamid   +2 more
exaly  

Final 5-Year Follow-Up Results Evaluating Neoadjuvant Talimogene Laherparepvec Plus Surgery in Advanced Melanoma

JAMA Oncology, 2023
exaly  

Ipilimumab/nivolumab/talimogene laherparepvec

Reactions Weekly, 2021
openaire   +1 more source

An evaluation of talimogene laherparepvec for the treatment of melanoma

Expert Opinion on Biological Therapy, 2020
Jonathan S Zager
exaly  

Pembrolizumab/talimogene laherparepvec

Reactions Weekly, 2018
openaire   +2 more sources

Talimogene-laherparepvec

Reactions Weekly
openaire   +1 more source

Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma

American Journal of Clinical Dermatology, 2016
Howard L Kaufman
exaly  

Real-World Use of Talimogene Laherparepvec in German Patients with Stage IIIB to IVM1a Melanoma: A Retrospective Chart Review and Physician Survey

Advances in Therapy, 2018
Sebastian Haferkamp, Carsten Weishaupt
exaly